Patents Assigned to VIADIGM LLC
  • Publication number: 20220213430
    Abstract: The present technology provides a method for the effective participation of tissue, for example, amniotic, chorionic, umbilical cord, or a combination thereof to create a flowable suspension for therapeutic purposes. In contrast to other technologies, the present technology does not require cryogenic milling or pre-freezing to harden the tissue for effective particulation and is further capable of preserving the viability of endogenous cell types in contrast to previous methodologies.
    Type: Application
    Filed: April 24, 2020
    Publication date: July 7, 2022
    Applicant: VIADIGM LLC
    Inventor: Jeremy B. Vines